GSK3B and Alzheimer disease: Inhibition of GSK-3β activity has been shown to increase synaptic plasticity, reduce synaptic dysfunction, consolidate memory, rescue cognitive and memory deficits [67], thus plays a role in preventing and alleviating AD.